Horace Mungin v. HHS - Pneumococcal, left shoulder pain, left arm cellulitis, and index finger stenosing tenosynovitis (2017)
Case summary [AI summaries can sometimes make mistakes]
Horace Mungin filed a petition on August 9, 2016, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered left shoulder pain, left arm cellulitis, and index finger stenosing tenosynovitis as a result of receiving the Prevnar 13 pneumococcal conjugate vaccine on July 21, 2015.
Mr. Mungin further alleged that these conditions had residual effects lasting more than six months.
The respondent denied that the vaccine caused these injuries. However, both parties agreed to settle the case through a stipulation filed on September 25, 2017.
Special Master Brian H. Corcoran reviewed the file and concluded that the stipulation was reasonable, adopting it as his decision.
Based on this stipulation, Special Master Corcoran awarded Mr. Mungin $10,000.00 as compensation for all damages.
The decision was entered on November 14, 2017. Petitioner was represented by Jeffrey S.
Pop of Jeffrey S. Pop & Associates, and respondent was represented by Douglas Ross of the U.S.
Department of Justice. The public decision does not describe the specific onset of symptoms, medical examinations, diagnostic tests, treatments, or the mechanism of causation.
Theory of causation
Petitioner Horace Mungin alleged that the Prevnar 13 pneumococcal conjugate vaccine administered on July 21, 2015, caused left shoulder pain, left arm cellulitis, and index finger stenosing tenosynovitis, with residual effects lasting over six months. Respondent denied causation. The parties reached a settlement via stipulation filed September 25, 2017. Special Master Brian H. Corcoran adopted the stipulation, awarding $10,000.00 in lump sum to Petitioner. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. Petitioner's counsel was Jeffrey S. Pop, and respondent's counsel was Douglas Ross. The decision date was November 14, 2017.
Source PDFs
USCOURTS-cofc-1_16-vv-00968